79
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Uncommon histiocyte-rich pseudotumor after chemotherapy in peripheral T-cell lymphoma

, , &
Pages 2013-2015 | Received 15 Jan 2022, Accepted 15 Mar 2022, Published online: 31 Mar 2022

References

  • Abdou AG, Kandil M, Eldien MS, et al. Splenic histiocyte-rich pseudotumor following chemotherapy for non hodgkin diffuse large B cell lymphoma. Pathologica. 2016;108(3):140–143.
  • Chandra P, Wen YH, Tuli S, et al. Postchemotherapy histiocyte-rich pseudotumor involving the spleen. Am J Clin Pathol. 2009;132(3):342–348.
  • Hod N, Lantsberg S, Anconina R, et al. Postchemotherapy histiocyte-rich pseudotumor of the spleen simulating residual disease in a patient with non-Hodgkin lymphoma on FDG PET/CT. Clin Nucl Med. 2019;44(6):e409–e12.
  • Naumann R, Vaic A, Beuthien-Baumann B, et al. Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma. Br J Haematol. 2001;115(4):793–800.
  • Zinzani PL, Tani M, Trisolini R, et al. Histological verification of positive positron emission tomography findings in the follow-up of patients with mediastinal lymphoma. Haematologica. 2007;92(6):771–777.
  • Pina-Oviedo S, Miranda RN, Medeiros LJ. Cancer therapy-associated lymphoproliferative disorders: an under-recognized type of immunodeficiency-associated lymphoproliferative disorder. Am J Surg Pathol. 2018;42(1):116–129.
  • Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the imaging subcommittee of international harmonization project in lymphoma. J Clin Oncol. 2007;25(5):571–578.
  • Barrington SF, O'Doherty MJ. Limitations of PET for imaging lymphoma. Eur J Nucl Med Mol Imaging. 2003;30(Suppl 1):S117–S127.
  • Cayci Z, Ozturk K, Ustun C, et al. Sarcoid-like histiocytic proliferations in patients with lymphoma can be FDG-avid concerning for refractory or recurrent disease. Clin Lymphoma Myeloma Leuk. 2019;19(11):e597–e601.
  • Fang H, Chuang HH, Strati P, et al. Postchemotherapy histiocyte-rich pseudotumor mimicking residual lymphoma: a report of 11 cases correlating clinicopathologic and radiologic findings. Am J Surg Pathol. 2021; 45(2):160–168.
  • Ford CD, Gabor F, Morgan R, et al. False-positive restaging PET scans involving the spleen in two patients with aggressive non-Hodgkin lymphoma. Clin Nucl Med. 2006;31(7):391–393.
  • Nilak YD, Nilak A, Shafeek S, et al. Benign histiocyte-rich pseudotumor in post treatment mediastinal Hodgkin's lymphoma. Radiol Case Rep. 2020;15(2):156–160.
  • Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer; 2017.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.